Role of C-reactive protein in cardiovascular disease (Q28166927)

Annals of Pharmacotherapy

Europe PubMed Central

title

Role of C-reactive protein in cardiovascular disease (English)

0 references

main subject

cardiovascular disease

1 reference

James M Backes

1

0 references

Patricia A Howard

series ordinal

2

0 references

Patrick M Moriarty

series ordinal

3

0 references

language of work or name

English

0 references

publication date

January 2004

0 references

published in

0 references

volume

38

0 references

page(s)

110-8

0 references

issue

1

0 references

cites work

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 April 2017

1 reference

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

21 April 2017

1 reference

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 April 2017

1 reference

Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay

21 April 2017

1 reference

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

21 April 2017

1 reference

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 April 2017

1 reference

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 April 2017

1 reference

Lipids, risk factors and ischaemic heart disease

21 April 2017

1 reference

Statins and the acute-phase response

21 January 2018

1 reference

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

21 January 2018

1 reference

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients

21 January 2018

1 reference

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect

21 January 2018

1 reference

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

Short-term effects of atorvastatin on C-reactive protein

21 January 2018

1 reference

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

Relation of inflammation and benefit of statins after percutaneous coronary interventions

21 January 2018

1 reference

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

21 January 2018

1 reference

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

21 January 2018

1 reference

Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation

21 January 2018

1 reference

C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease

21 January 2018

1 reference

High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction

21 January 2018

1 reference

Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1.

21 January 2018

1 reference

Effect of losartan on plasma C-reactive protein in type 2 diabetic patients with microabluminuria

21 January 2018

1 reference

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

21 January 2018

1 reference

Hormone replacement therapy and increased plasma concentration of C-reactive protein

21 January 2018

1 reference

Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women

21 January 2018

1 reference

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response

21 January 2018

1 reference

Weight loss reduces C-reactive protein levels in obese postmenopausal women

21 January 2018

1 reference

Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women

21 January 2018

1 reference

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

21 January 2018

1 reference

Plasma levels of C-reactive protein after coronary stent implantation

21 January 2018

1 reference

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D203

1 reference

Consolidated OpenCitations Corpus – April 2017

4249469

4249469

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference